BillionToOne, Inc. (BLLN) vs Veracyte, Inc. (VCYT)
BillionToOne, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $5.9B against $3.9B — 1.5× the size. Veracyte, Inc. trades at the lower P/E: 31.5× against 119×. Veracyte, Inc. has the higher net margin (20.4% vs 8.35%) and the lower return on invested capital (7.32% vs 34.1%). Across the 19 metrics below, Veracyte, Inc. leads on 14 and BillionToOne, Inc. on 5.
Valuation
Profitability
| Metric | BLLN | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.27% | 71.71% | 50.89% |
| Operating margin | 10.90% | 18.82% | (8.57%) |
| Net margin | 8.35% | 20.37% | (6.37%) |
| Free cash flow margin | 8.35% | 29.54% | 0.00% |
| Return on equity | 23.27% | 8.77% | (2.92%) |
| Return on assets | 9.09% | 8.09% | (6.71%) |
| Return on invested capital | 34.10% | 7.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack